Talazoparib for BRCA-mutated advanced breast cancer

被引：4
|
作者：
Gunjur, Ashray
机构：
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 10期
关键词：
D O I：
10.1016/S1470-2045(18)30650-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E511 / E511
页数：1
相关论文
共 50 条
  • [31] Olaparib plus Trastuzumab in HER2[+] BRCA-Mutated Advanced Breast Cancer Patients: The OPHELIA Study
    Ales-Martinez, Jose E.
    Balmana, Judith
    Sanchez-Rovira, Pedro
    Bofill, Francisco Javier Salvador
    Garcia-Saenz, Jose Angel
    Pimentel, Isabel
    Murillo, Serafin Morales
    Fernandez, Adela
    Martinez, Ainhara Lahuerta
    Ferrer, Neus
    Zamora, Pilar
    Bermejo, Begona
    Diaz-Redondo, Tamara
    Lopez-Ceballos, Maria Helena
    Galan, Maria
    Malfettone, Andrea
    Calabuig, Laura
    Sampayo-Cordero, Miguel
    Perez-Garcia, Jose Manuel
    Cortes, Javier
    Llombart-Cussac, Antonio
    CANCER RESEARCH, 2023, 83 (05)
  • [32] Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
    Arjun Mittra
    Geraldine H. O’ Sullivan Coyne
    Jennifer Zlott
    Shivaani Kummar
    Robert Meehan
    Lawrence Rubinstein
    Lamin Juwara
    Deborah Wilsker
    Jiuping Ji
    Brandon Miller
    Tony Navas
    Katherine V. Ferry-Galow
    Andrea Regier Voth
    Ting-Chia Chang
    Shahanawaz Jiwani
    Ralph E. Parchment
    James H. Doroshow
    Alice P. Chen
    Cancer Chemotherapy and Pharmacology, 2024, 93 : 177 - 189
  • [33] Carboplatin and talazoparib combination therapy results in differential efficacy and hematologic toxicity in BRCA-mutated patients
    Dhawan, Mallika S.
    Aggarwal, Rahul
    Bartelink, Imke
    Leng, Jim
    Thomas, Scott
    Pawlowska, Nela
    Stevenson, Laurie
    Chien, Amy Jo
    Kelley, Robin Kate
    Munster, Pamela N.
    CANCER RESEARCH, 2016, 76
  • [34] Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
    Mittra, Arjun
    Coyne, Geraldine H. O' Sullivan
    Zlott, Jennifer
    Kummar, Shivaani
    Meehan, Robert
    Rubinstein, Lawrence
    Juwara, Lamin
    Wilsker, Deborah
    Ji, Jiuping
    Miller, Brandon
    Navas, Tony
    Ferry-Galow, Katherine V.
    Voth, Andrea Regier
    Chang, Ting-Chia
    Jiwani, Shahanawaz
    Parchment, Ralph E.
    Doroshow, James H.
    Chen, Alice P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (03) : 177 - 189
  • [35] Poly ADP ribose polymerase (PARP) for the treatment of BRCA-mutated advanced ovarian cancer
    Yunokawa, Mayu
    ANNALS OF ONCOLOGY, 2019, 30 : 47 - 47
  • [36] Leptomeningeal carcinomatosis in BRCA-mutated pancreatic cancer.
    Slostad, Jessica Anne
    Hallemeier, Christopher Leigh
    Bamlet, William R.
    Couch, Fergus
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [37] Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer
    Sonderstrup, I. M. H.
    Jensen, M. B.
    Ejlertsen, B.
    Eriksen, J. O.
    Gerdes, A. M.
    Kruse, T. A.
    Larsen, M. J.
    Thomassen, M.
    Laenkholm, A. V.
    ACTA ONCOLOGICA, 2019, 58 (03) : 363 - 370
  • [38] BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
    Arun, Banu
    Couch, Fergus J.
    Abraham, Jean
    Tung, Nadine
    Fasching, Peter A.
    BRITISH JOURNAL OF CANCER, 2024, 131 (09) : 1400 - 1414
  • [39] Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy
    Cruz, Cristina
    Llop-Guevara, Alba
    Garber, Judy E.
    Arun, Banu K.
    Perez Fidalgo, Jose A.
    Lluch, Ana
    Telli, Melinda L.
    Fernandez, Cristian
    Kahatt, Carmen
    Galmarini, Carlos M.
    Soto-Matos, Arturo
    Alfaro, Vicente
    Perez de la Haza, Aitor
    Domchek, Susan M.
    Antolin, Silvia
    Vahdat, Linda
    Tung, Nadine M.
    Lopez, Rafael
    Arribas, Joaquin
    Vivancos, Ana
    Baselga, Jose
    Serra, Violeta
    Balmana, Judith
    Isakoff, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (31) : 3134 - +
  • [40] Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review
    Sun, Ximu
    Wang, Xin
    Zhang, Jie
    Zhao, Zhixia
    Feng, Xin
    Liu, Lihong
    Ma, Zhuo
    BREAST, 2021, 60 : 26 - 34
12345